DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Chloroprocaine hydrochlorideis the generic ingredient in four branded drugs marketed by Hospira, West-ward Pharms Int, Fresenius Kabi Usa, and B Braun Medical Inc, and is included in five NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.
Chloroprocaine hydrochloride has twenty-nine patent family members in twenty-six countries.
There are four drug master file entries for chloroprocaine hydrochloride. Five suppliers are listed for this compound.
Summary for chloroprocaine hydrochloride
Recent Clinical Trials for chloroprocaine hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
|The University of Texas Health Science Center, Houston||Phase 4|
|Oregon Health and Science University||Phase 4|
|B. Braun Medical Inc.||Phase 4|
Pharmacology for chloroprocaine hydrochloride
|Drug Class||Ester Local Anesthetic |
|Physiological Effect||Local Anesthesia |
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Hospira||CHLOROPROCAINE HYDROCHLORIDE||chloroprocaine hydrochloride||INJECTABLE;INJECTION||087446-001||Apr 16, 1982||AP||RX||No||No||Start Trial||Start Trial||Start Trial|
|Fresenius Kabi Usa||NESACAINE||chloroprocaine hydrochloride||INJECTABLE;INJECTION||009435-002||Approved Prior to Jan 1, 1982||AP||RX||Yes||No||Start Trial||Start Trial||Start Trial|
|Hospira||CHLOROPROCAINE HYDROCHLORIDE||chloroprocaine hydrochloride||INJECTABLE;INJECTION||087447-001||Apr 16, 1982||AP||RX||No||No||Start Trial||Start Trial||Start Trial|
|Fresenius Kabi Usa||NESACAINE-MPF||chloroprocaine hydrochloride||INJECTABLE;INJECTION||009435-007||May 2, 1996||AP||RX||Yes||Yes||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.